Fibromyalgia: Mechanisms and potential impact of the ACR 2010 classification criteria

Nature Reviews Rheumatology

Volumn 8, Issue 2, 2012, Pages 108-116

  McBeth, John ^a   Mulvey, Matthew R ^b  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE; MILNACIPRAN; PREGABALIN;

AGE DISTRIBUTION; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FIBROMYALGIA; HTR2A GENE; HUMAN; MOLECULAR PATHOLOGY; NOCICEPTION; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR GENE; REVIEW; RISK ASSESSMENT; RISK FACTOR;

CHRONIC PAIN; COMORBIDITY; FIBROMYALGIA; HUMANS; HYPERALGESIA; JOINTS; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL; TOUCH;

EID: 84856599951     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2011.216     Document Type: Review

References (136)

1. Wolfe, F. et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 33, 160-172 (1990). (Pubitemid 20098653)
2. Wolfe, F. et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. (Hoboken.) 62, 600-610 (2010).
3. Gowers, W. R. Lumbago: Its lessons and analogues. Br. Med. J. 1, 117-121 (1904).
4. Stockman, R. The causes, pathology, and treatment of chronic rheumatism. Edinburgh Medical Journal 15, 107-116 (1904).
5. Smythe, H. A. Non-articular rheumatism and the fibrosists syndrome in Arthritis and Allied Conditions (ed. Hollander, J. L.) 874-884 (Lea & Febiger, 1972).
6. Hench, P. K. Fibrositis. Arthritis Rheum. 196, 1087-1088 (1975).
7. Smythe, H. A. & Moldofsky, H. Two contributions to understanding of the "fibrositis" syndrome. Bull. Rheum. Dis. 28, 928-931 (1977).
8. Yunus, M., Masi, A. T., Calabro, J. J., Miller, K. A. & Feigenbaum, S. L. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin. Arthritis Rheum. 11, 151-171 (1981). (Pubitemid 11015513)
9. Goldenberg, D. L. Fibromyalgia syndrome. An emerging but controversial condition. Journal of American Medical Association 257:20, 2782-2787 (1987). (Pubitemid 17066523)
10. Wolfe, F. & Cathey, M. A. Prevalence of primary and secondary fibrositis. J. Rheumatol. 10, 965-968 (1983). (Pubitemid 14156292)
11. McBeth, J. & Jones, K. A. Epidemiology of chronic musculoskeletal pain. Best. Pract. Res. Clin. Rheumatol. 21, 403-425 (2007). (Pubitemid 46972006)
12. McBeth, J. et al. The prevalence of "unexplained" chronic widespread pain in the general population: Results from the General Practice Symptoms Study. Rheumatology 47 [S2], ii184. 2008. Ref Type: Abstract.
13. McBeth, J., Nicholl, B. I., Cordingley, L., Davies, K. A. & Macfarlane, G. J. Chronic widespread pain predicts physical inactivity: results from the prospective EPIFUND study. Eur. J. Pain 14, 972-979 (2010).
14. Croft, P., Rigby, A. S., Boswell, R., Schollum, J. & Silman, A. The prevalence of chronic widespread pain in the general population. J. Rheumatol. 20, 710-713 (1993). (Pubitemid 23138864)
15. Wolfe, F., Ross, K., Anderson, J., Russell, I. J. & Hebert, L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 38, 19-28 (1995).
16. McBeth, J. The epidemiology of chronic widespread pain and fibromyalgia in Fibromyalgia and other central pain syndromes (eds. Wallace, D. J. & Clauw, D. J.) 17-28 (Lippincott Williams & Wilkins, Philidelphia, 2005).
17. Leveille, S. G. et al. Chronic musculoskeletal pain and the occurrence of falls in an older population. JAMA 302, 2214-2221 (2009).
18. Thomas, E., Peat, G., Harris, L., Wilkie, R. & Croft, P. R. The prevalence of pain and pain interference in a general population of older adults: cross-sectional findings from the North Staffordshire Osteoarthritis Project (NorStOP). Pain 110, 361-368 (2004). (Pubitemid 38953301)
19. White, K. P. & Harth, M. Classification, epidemiology, and natural history of fibromyalgia. Current Pain & Headache Reports. 5, 320-329 (2001).
20. Carmona, L., Ballina, J., Gabriel, R. & Laffon, A. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann. Rheum. Dis. 60, 1040-1045 (2001). (Pubitemid 32989176)
21. Makela, M. & Heliovaara, M. Prevalence of primary fibromyalgia in the Finnish population. Br. Med. J. 303, 216-219 (1991).
22. Senna, E. R. et al. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J. Rheumatol. 31, 594-597 (2004).
23. Lawrence, R. C. et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 41, 778-799 (1998). (Pubitemid 28225778)
24. Branco, J. C. et al. Prevalence of fibromyalgia: a survey in five European countries. Semin. Arthritis Rheum. 39, 448-453 (2010).
25. Macfarlane, G. J. et al. Evaluation of work-related psychosocial factors and regional musculoskeletal pain: results from a EULAR Task Force. Ann. Rheum. Dis. 68, 885-891 (2009).
26. McBeth, J. et al. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study. Arthritis Rheum. 56, 360-371 (2007). (Pubitemid 46106210)
27. Chiu, Y. H. et al. Poor sleep and depression are independently associated with a reduced pain threshold. Results of a population based study. Pain 115, 316-321 (2005). (Pubitemid 40725287)
28. Gupta, A. et al. The role of psychosocial factors in predicting the onset of chronic widespread pain: results from a prospective population-based study. Rheumatology (Oxford) 46, 666-671 (2007). (Pubitemid 46523314)
29. Jones, E. A. et al. What characterizes persons who do not report musculoskeletal pain? Results from a 4-year population-based longitudinal study (the Epifund study). J. Rheumatol. 36, 1071-1077 (2009).
30. McBeth, J. et al. Hypothalamic-pituitary-adrenal stress axis function and the relationship with chronic widespread pain and its antecedents. Arthritis Res. Ther. 7, R992-R1000 (2005).
31. Robinson, K. L., McBeth, J. & Macfarlane, G. J. Psychological distress and premature mortality in the general population: a prospective study. Ann. Epidemiol. 14, 467-472 (2004). (Pubitemid 39061156)
32. Nicholl, B. I. et al. Premorbid psychosocial factors are associated with poor health-related quality of life in subjects with new onset of chronic widespread pain-results from the EPIFUND study. Pain 141, 119-126 (2009).
33. Davies, K. A. et al. Restorative sleep predicts the resolution of chronic widespread pain: results from the EPIFUND study. Rheumatology (Oxford) 47, 1809-1813 (2008).
34. Kennedy, M. & Felson, D. T. A prospective long-term study of fibromyalgia syndrome. Arthritis Rheum. 39, 682-685 (1996). (Pubitemid 26118048)
35. Waylonis, G. W. & Perkins, R. H. Post-traumatic fibromyalgia. A long-term follow-up. Am. J. Phys. Med. Rehabil. 73, 403-412 (1994).
36. Granges, G., Zilko, P. & Littlejohn, G. O. Fibromyalgia Syndrome: assessment of the severity of the condition 2 years after diagnosis. J. Rheumatol. 21, 523-529 (1994). (Pubitemid 24102840)
37. Bengtsson, A. & Backman, E. Long-term follow up of fibromyalgia patients. Scand. J. Rheumatol. 21, 98 (1992).
38. Walitt, B. et al. The longitudinal outcome of fibromyalgia: a study of 1555 patients. J. Rheumatol. 38, 2238-2246 (2011).
39. Noller, V. & Sprott, H. Prospective epidemiological observations on the course of the disease in fibromyalgia patients. J. Negat. Results Biomed. 2, 4 (2003).
40. van Koulil, S., van Lankveld, W., Kraaimaat, F., van Riel, P. & Evers, A. Risk factors for longer term psychological distress in well-functioning fibromyalgia patients: a prospective study into prognostic factors. Patient Educ. Couns. 80, 126-129 (2010).
41. Boehm, A., Eisenberg, E. & Lampel, S. The contribution of social capital and coping strategies to functioning and quality of life of patients with fibromyalgia. Clin. J. Pain 27, 233-239 (2011).
42. Wigers, S. H. Fibromyalgia outcome: The predictive value of symptom duration, physical activity, disability pension, and critical life events-a 4.5 year prospective study. J. Psychosom. Res. 41, 235-243 (1996). (Pubitemid 26385381)
43. Macfarlane, G. J. et al. The natural history of chronic pain in the community: a better prognosis than in the clinic? J. Rheumatol. 23, 1617-1620 (1996).
44. Papageorgiou, A. C., Silman, A. J. & Macfarlane, G. J. Chronic widespread pain in the population: a seven year follow up study. Ann. Rheum. Dis. 61, 1071-1074 (2002). (Pubitemid 35397353)
45. Carette, S. Fibromyalgia 20 years later: What have we really accomplished. J. Rheumatol. 22, 590-594 (1995).
46. Burckhardt, C. S. et al. Guideline for the management of fibromyalgia syndrome pain in adults and children in APS Clinical Practice Guideline Series No. 4 (American Pain Society, Glenview, IL, 2005).
47. Carville, S. F. et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann. Rheum. Dis. 67, 536-541 (2008). (Pubitemid 351498437)
48. Eich, W. et al. Definition, classification and diagnosis of fibromyalgia syndrome. Schmerz. 22, 255-266 (2008).
49. Di Franco, M. et al. Pharmacological treatment of fibromyalgia. Clin. Exp. Rheumatol. 28, S110-S116 (2010).
50. van Koulil S. et al. Tailored cognitive-behavioral therapy and exercise training for high-risk patients with fibromyalgia. Arthritis Care Res. (Hoboken.) 62, 1377-1385 (2010).
51. Hauser, W., Bernardy, K., Arnold, B., Offenbacher, M. & Schiltenwolf, M. Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials. Arthritis Rheum. 61, 216-224 (2009).
52. Macfarlane, G. J., Norrie, G., Atherton, K., Power, C. & Jones, G. T. The influence of socioeconomic status on the reporting of regional and widespread musculoskeletal pain: results from the 1958 British Birth Cohort Study. Ann. Rheum. Dis. 68, 1591-1595 (2009).
53. Roizenblatt, S., Neto, N. S. & Tufik, S. Sleep Disorders and Fibromyalgia. Curr. Pain Headache Rep. 15, 347-357 (2011).
54. Ablin, J. N., Buskila, D. & Clauw, D. J. Biomarkers in fibromyalgia. Curr. Pain Headache Rep. 13, 343-349 (2009).
55. Jones, G. T. et al. Role of road traffic accidents and other traumatic events in the onset of chronic widespread pain: Results from a population-based prospective study. Arthritis Care Res. (Hoboken) 63, 696-701 (2011).
56. Mork, P. J., Vasseljen, O. & Nilsen, T. I. Association between physical exercise, body mass index, and risk of fibromyalgia: longitudinal data from the Norwegian Nord-Trondelag Health Study. Arthritis Care Res. (Hoboken) 62, 611-617 (2010).
57. Choi, C. J., Knutsen, R., Oda, K., Fraser, G. E. & Knutsen, S. F. The association between incident self-reported fibromyalgia and nonpsychiatric factors: 25-years follow-up of the Adventist Health Study. J. Pain 11, 994-1003 (2010).
58. Holliday, K. L. et al. Genetic variation in neuroendocrine genes associates with somatic symptoms in the general population: results from the EPIFUND study. J. Psychosom. Res. 68, 469-474 (2010).
59. Holliday, K. L. et al. Genetic variation in the hypothalamic-pituitary- adrenal stress axis influences susceptibility to musculoskeletal pain: results from the EPIFUND study. Ann. Rheum. Dis. 69, 556-560 (2010).
60. Geisser, M. E. et al. The association between experimental and clinical pain measures among persons with fibromyalgia and chronic fatigue syndrome. Eur. J. Pain 11, 202-207 (2007). (Pubitemid 44820896)
61. Staud, R. New evidence for central sensitization in patients with fibromyalgia. Curr. Rheumatol. Rep. 6, 259 (2004).
62. Staud, R., Nagel, S., Robinson, M. E. & Price, D. D. Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study. Pain 145, 96-104 (2009).
63. Yunus, M. B. Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation. J. Rheumatol. 19, 846-850 (1992).
64. Bennett, R. M., Jones, J., Turk, D. C., Russell, I. J. & Matallana, L. An internet survey of 2,596 people with fibromyalgia. BMC. Musculoskelet. Disord. 8, 27 (2007).
65. Clauw, D. J. Fibromyalgia: an overview. Am. J. Med. 122, S3-S13 (2009).
66. Dadabhoy, D., Crofford, L. J., Spaeth, M., Russell, I. J. & Clauw, D. J. Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome. Arthritis Res. Ther. 10, 211 (2008).
67. McBeth, J. An Epidemiological Study of Chronic Widespread Pain. Thesis, University of Manchester (2000).
68. McBeth, J., Macfarlane, G. J., Hunt, I. M. & Silman, A. J. Risk factors for persistent chronic widespread pain: a community-based study. Rheumatology (Oxford) 40, 95-101 (2001).
69. McBeth, J., Harkness, E. F., Silman, A. J. & Macfarlane, G. J. Mechanical injury and psychosocial factors in the work-place predict the onset of widespread body pain: a 2-year prospective study amongst cohorts of newly-employed workers. Arthritis Rheum. 48, S237 (2003).
70. McBeth, J., Macfarlane, G. J. & Silman, A. J. Does chronic pain predict future psychological distress? Pain 96, 239-245 (2002). (Pubitemid 34327869)
71. McBeth, J., Macfarlane, G. J., Benjamin, S. & Silman, A. J. Features of somatization predict the onset of chronic widespread pain: results of a large population-based study. Arthritis Rheum. 44, 940-946 (2001). (Pubitemid 32319787)
72. Davies, K. A. et al. The association between neighbourhood socio-economic status and the onset of chronic widespread pain: results from the EPIFUND study. Eur. J. Pain 13, 635-640 (2009).
73. Theadom, A., Cropley, M. & Humphrey, K. L. Exploring the role of sleep and coping in quality of life in fibromyalgia. J. Psychosom. Res. 62, 145-151 (2007). (Pubitemid 46161592)
74. Wolfe, F. & Pincus, T. Standard self-report questionnaires in routine clinical and research practice-An opportunity for patients and rheumatologists. J. Rheumatol. 18, 643-646 (1991).
75. Moldofsky, H. & Scarisbrick, P. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom. Med. 38, 35-44 (1976).
76. Solitar, B. M. Fibromyalgia: knowns, unknowns, and current treatment. Bull. NYU Hosp. Jt Dis. 68, 157-161 (2010).
77. Aaron, L. A. et al. Perceived physical and emotional trauma as precipitating events in fibromyalgia. Associations with health care seeking and disability status but not pain severity. Arthritis Rheum. 40, 453-460 (1997).
78. White, K. P., Nielson, W. R., Harth, M., Ostbye, T. & Speechley, M. Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample. J. Rheumatol. 29, 588-594 (2002). (Pubitemid 34202833)
79. Al-Allaf, A. W. et al. A case-control study examining the role of physical trauma in the onset of fibromyalgia syndrome. Rheumatology. (Oxford) 41, 450-453 (2002). (Pubitemid 34537845)
80. Buskila, D., Neumann, L., Vaisberg, G., Alkalay, D. & Wolfe, F. Increased rates of fibromyalgia following cervical spine injury. A controlled study of 161 cases of traumatic injury. Arthritis Rheum. 40, 446-452 (1997).
81. Tishler, M., Levy, O., Maslakov, I., Bar-Chaim, S. & mit-Vazina, M. Neck injury and fibromyalgia -are they really associated? J. Rheumatol. 33, 1183-1185 (2006). (Pubitemid 43825474)
82. Tishler, M., Levy, O. & mit-Vazina, M. Can fibromyalgia be associated with whiplash injury? A 3-year follow-up study. Rheumatol. Int. 31, 1209-1213 (2010).
83. Wynne-Jones, G., Jones, G. T., Wiles, N. J., Silman, A. J. & Macfarlane, G. J. Predicting new onset of widespread pain following a motor vehicle collision. J. Rheumatol. 33, 968-974 (2006).
84. Matsuda, J. B. et al. Serotonin receptor (5-HT2A) and catechol-O-methyltransferase (COMT) gene polymorphisms: triggers of fibromyalgia? Rev. Bras. Reumatol. 50, 141-149 (2010).
85. Hocking, L. J. et al. Genetic variation in the β2-adrenergic receptor but not catecholamine-O-methyltransferase predisposes to chronic pain: results from the 1958 British Birth Cohort Study. Pain 149, 143-151 (2010).
86. Nicholl, B. I. et al. No evidence for a role of the catechol-O- methyltransferase pain sensitivity haplotypes in chronic widespread pain. Ann. Rheum. Dis. 69, 2009-2012 (2010).
87. Nicholl, B. I. et al. Association of HTR2A polymorphisms with chronic widespread pain and the extent of musculoskeletal pain: results from two population-based cohorts. Arthritis Rheum. 63, 810-818 (2011).
88. Lee, Y. H., Choi, S. J., Ji, J. D. & Song, G. G. Candidate gene studies of fibromyalgia: a systematic review and meta-analysis. Rheumatol. Int. http://dx.doi.org/10.1007/s00296-010-1678-9.
89. Nielsen, L. A. & Henriksson, K. G. Pathophysiological mechanisms in chronic musculoskeletal pain (fibromyalgia): the role of central and peripheral sensitization and pain disinhibition. Best. Pract. Res. Clin. Rheumatol. 21, 465-480 (2007). (Pubitemid 46972010)
90. Schmidt-Wilcke, T. & Clauw, D. J. Fibromyalgia: from pathophysiology to therapy. Nat. Rev. Rheumatol. 7, 518-527 (2011).
91. Clauw, D. J. Fibromyalgia: Update on mechanisms and management. J. Clin. Rheumatol. 13, 102-109 (2007). (Pubitemid 46597679)
92. Gracely, R. H., Petzke, F., Wolf, J. M. & Clauw, D. J. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum. 46, 1333-1343 (2002). (Pubitemid 34525843)
93. Staud, R., Robinson, M. E. & Price, D. D. Isometric exercise has opposite effects on central pain mechanisms in fibromyalgia patients compared to normal controls. Pain 118, 176-184 (2005). (Pubitemid 41566597)
94. Geisser, M. E. et al. Perception of noxious and innocuous heat stimulation among healthy women and women with fibromyalgia: association with mood, somatic focus, and catastrophizing. Pain 102, 243-250 (2003). (Pubitemid 36369302)
95. 2 laser stimulation in subjects with fibromyalgia syndrome. Pain 58, 185-193 (1994). (Pubitemid 24263611)
96. Kosek, E. & Hansson, P. Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain 70, 41-51 (1997). (Pubitemid 27128296)
97. Lautenbacher, S. & Rollman, G. B. Possible deficiencies of pain modulation in fibromyalgia. Clin. J. Pain 13, 189-196 (1997). (Pubitemid 27524077)
98. Petzke, F., Clauw, D. J., Ambrose, K., Khine, A. & Gracely, R. H. Increased pain sensitivity in fibromyalgia: effects of stimulus type and mode of presentation. Pain 105, 403-413 (2003). (Pubitemid 37186903)
99. Julien, N., Goffaux, P., Arsenault, P. & Marchand, S. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 114, 295-302 (2005). (Pubitemid 40279112)
100. Buskila, D. & Neumann, L. Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM. J. Rheumatol. 24, 941-944 (1997). (Pubitemid 27223632)
101. Fitzcharles, M. A. & Boulos, P. Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals. Rheumatology (Oxford) 42, 263-267 (2003). (Pubitemid 36305612)
102. Choy, E. H. et al. Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome. J. Rheumatol. 36, 2330-2334 (2009).
103. Mease, P. et al. Fibromyalgia syndrome. J. Rheumatol. 34, 1415-1425 (2007). (Pubitemid 46898129)
104. Mease, P. J. et al. Fibromyalgia syndrome. J. Rheumatol. 32, 2270-2277 (2005). (Pubitemid 41587880)
105. Mease, P. J. et al. The efficacy and safety of milnacipran for treatment of fibromyalgiae. A randomized, double-blind, placebo-controlled trial. J. Rheumatol. 36, 398-409 (2009).
106. Wolfe, F. & Michaud, K. Outcome and predictor relationships in fibromyalgia and rheumatoid arthritis: evidence concerning the continuum versus discrete disorder hypothesis. J. Rheumatol. 36, 831-836 (2009).
107. Toda, K. Preliminary diagnostic criteria for fibromyalgia should be partially revised: comment on the article by Wolfe et al. Arthritis Care Res. (Hoboken) 63, 308-309 (2011).
108. Wolfe, F. et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J. Rheumatol. 38, 1113-1122 (2011).
109. Bennett, R. M. Fibrositis: misnomer for a common rheumatic disorder. West J. Med. 134, 405-413 (1981).
110. Payne, T. C. et al. Fibrositis and psychologic disturbance. Arthritis Rheum. 25, 213-217 (1982). (Pubitemid 12170281)
111. Campbell, S. M., Clark, S., Tindall, E. A., Forehand, M. E. & Bennett, R. M. Clinical characteristics of fibrositis I. A "blinded" controlled study of symptoms and tender points. Arthritis Rheum. 26, 817-824 (1983). (Pubitemid 13069725)
112. Yunus, M. B., Masi, A. T. & Aldag, J. C. Preliminary criteria for primary fibromyalgia syndrome (PFS): multivariate analysis of a consecutive series of PFS, other pain patients, and normal subjects. Clin. Exp. Rheumatol. 7, 63-69 (1989). (Pubitemid 19086246)
113. Wolfe, F., Cathey, M. A. & Kleinheksel, S. M. Fibrositis (Fibromyalgia) in rheumatoid arthritis. J. Rheumatol. 11:6, 814-818 (1984). (Pubitemid 15187515)
114. Hartz, A. & Kirchdoerfer, E. Undetected fibrositis in primary care practice. J. Fam. Pract. 25, 365-369 (1987). (Pubitemid 18010178)
115. Müller, W. The fibrositis syndrome: diagnosis, differential diagnosis and pathogenesis. Scand. J. Rheumatol. 65 (Suppl.) 40-53 (1987). (Pubitemid 17165513)
116. Greenfield, S., Fitzcharles, M. A. & Esdaile, J. M. Reactive fibromyalgia syndrome. Arthritis Rheum. 35, 678-681 (1992).
117. Middleton, G. D., McFarlin, J. E. & Lipsky, P. E. The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum. 8, 1181-1188 (1994). (Pubitemid 24313319)
118. Borenstein, D. Prevalence and treatment outcome of primary and secondary fibromyalgia in patients with spinal pain. Spine 20, 796-800 (1995).
119. Pamuk, G. E., Pamuk, O. N., Set, T., Harmandar, O. & Yesil, N. An increased prevalence of fibromyalgia in iron deficiency anemia and thalassemia minor and associated factors. Clin. Rheumatol. 27, 1103-1108 (2008).
120. Tietjen, G. E. et al. Allodynia in migraine: association with comorbid pain conditions. Headache 49, 1333-1344 (2009).
121. Bannwarth, B. et al. Fibromyalgia syndrome in the general population of France: a prevalence study. Joint Bone Spine 76, 184-187 (2009).
122. Almodovar, R. et al. Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage. Clin. Exp. Rheumatol. 28, S33-S39 (2010).
123. Jacobsen, S. & Danneskiold, S. Inter-relations between clinical parameters and muscle function in patients with primary fibromyalgia. Clin. Exp. Rheumatol. 7, 493-498 (1989). (Pubitemid 20069359)
124. Forseth, K. O. & Gran, J. T. The prevalence of fibromyalgia among women aged 20-49 years in Arendal, Norway. Scand. J. Rheumatol. 21, 74-78 (1992).
125. Lydell, C. & Meyers, O. L. The prevalence of fibromyalgia in a South African community [abstract]. Scand. J. Rheumatol. 94, (Suppl.) 8 (1992).
126. Raspe, H., Baugmanter, C. & Wolfe, F. The prevalence of fibromyalgia in a rural German community: how much difference do different criteria make? [abstract]. Arthritis Rheum. 36 (Suppl.), S48 (1993).
127. Prescott, E. et al. Fibromyalgia in the adult Danish population: I. A prevalence study. Scand. J. Rheumatol. 22, 233-237 (1993). (Pubitemid 23311153)
128. Buskila, D. et al. Assessment of nonarticular tenderness and prevalence of fibromyalgia in children. J. Rheumatol. 20, 368-370 (1993). (Pubitemid 23066054)
129. Clark, P., Burgos-Vargas, R., Medina-Palma, C., Lavielle, P. & Marina, F. F. Prevalence of fibromyalgia in children: a clinical study of Mexican children. J. Rheumatol. 25, 2009-2014 (1998). (Pubitemid 28459319)
130. White, K. P., Speechley, M., Harth, M. & Ostbye, T. The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J. Rheumatol. 26, 1570-1576 (1999). (Pubitemid 29317882)
131. Haq, S. A. et al. Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. J. Rheumatol. 32, 348-353 (2005). (Pubitemid 40209136)
132. Manahan, L. et al. Rheumatic pain in a Philippine village. A WHO-ILAR COPCORD Study. Rheumatol. Int. 5, 149-153 (1985). (Pubitemid 15007300)
133. Wenzel, H. G., Mykletun, A. & Nilsen, T. I. Symptom profile of persons self-reporting whiplash: a Norwegian population-based study (HUNT 2). Eur. Spine J. 18, 1363-1370 (2009).
134. Davatchi, F. et al. The prevalence of musculoskeletal complaints in a rural area in Iran: a WHO-ILAR COPCORD study (stage 1, rural study) in Iran. Clin. Rheumatol. 28, 1267-1274 (2009).
135. Santos, A. M. et al. Prevalence of fibromyalgia and chronic widespread pain in community-dwelling elderly subjects living in Sao Paulo, Brazil. Maturitas 67, 251-255 (2010).
136. Branco, J. C. et al. Prevalence of fibromyalgia: a survey in five European countries. Semin. Arthritis Rheum. 39, 448-453 (2010).